Athira Pharma Inc

NASDAQ:ATHA  
10.17
-0.13 (-1.26%)
Earnings Announcements

Athira Pharma QTRLY Loss Per Share $0.38

Published: 08/16/2021 20:15 GMT
Athira Pharma Inc (ATHA) - Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update.
Athira Pharma Inc - Initiated Open Label Extension for Lift-ad and Act-ad Trials of Ath-1017 Allowing for an Additional Six Months of Treatment.
Athira Pharma - Act-ad and Lift-ad Are Actively Recruiting; Topline Data of Act-ad Are Targeted by H1 2022.
Athira Pharma Inc - Qtrly Loss per Share $0.38.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.